Particle.news

Download on the App Store

Breakthrough Vascularized Stem Cell Islet Organoids Advance Diabetes Research

Researchers have developed vascularized pancreatic islet organoids that enhance β cell maturation and insulin secretion, with new efforts underway to model type 1 diabetes using patient-derived immune cells.

Image

Overview

  • For the first time, scientists led by Professor Maike Sander have created vascularized organoids of stem cell-derived pancreatic islets, closely mimicking in vivo physiology.
  • The vascularized organoids produce more mature β cells and significantly increase insulin secretion compared to non-vascularized models.
  • Endothelial cells and fibroblasts in the organoids drive β cell maturation through extracellular matrix formation and BMP secretion.
  • Microfluidic perfusion of vascularized organoids further enhances β cell maturity, demonstrating improved outcomes in diabetic mouse grafts, including reversal of diabetes symptoms.
  • Ongoing research aims to integrate patient-derived immune cells with vascularized organoids to study autoimmune β cell destruction in type 1 diabetes.